Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expanding Genetic Access for Prostate Cancer Survivors
Sponsor: Georgetown University
Summary
The goal of this study is to increase genetic education and genetic testing for hereditary cancer risk among prostate cancer survivors. The study will: Test the effectiveness of a digital guide (DG+) vs. print guide (Print+) vs. enhanced usual care (EUC) on engagement in genetic education and uptake of genetic testing. Evaluate the impact of the DG+ vs. Print+ vs. EUC on the process that participants use to make decisions and evaluate effects on well-being (also called psychosocial outcomes). Explore the ways (methods) that influence how participants experience the intervention. The main questions this study aims to answer are: which group - the digital guide (DG+) group, print (Print+) group or the EUC group - is more likely to request genetic testing and which group is more likely to get (engage with) genetic education. Participants will be randomly assigned to either the digital guide (DG+) group, the print guide (Print+) group or EUC group. Each group will receive genetic education and have an opportunity to request genetic testing. Researchers will compare the three groups to determine which is most most likely to complete genetic testing (GT) and which group engages more with genetic education.
Official title: Expanding Genetic Access and Guided Education for Prostate Cancer Survivors
Key Details
Gender
MALE
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2026-08-01
Completion Date
2030-07-31
Last Updated
2026-06-01
Healthy Volunteers
No
Interventions
Print Genetic Education Guide
Consists of clinical letter, genetic testing kit, and a print genetic education guide along with streamlined access to genetic testing for hereditary cancer risk.
Digital Guide Genetic Education Guide
Consists of clinical letter, genetic testing kit, and access to a genetic education digital guide along with streamlined access to genetic testing for hereditary cancer risk.
Enhanced Usual Care
Consists of clinical letter and recommendation/referral to schedule a genetic counseling session.
Locations (2)
Georgetown University Medical Center/Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States
Rutgers University/Rutgers Cancer Institute
New Brunswick, New Jersey, United States